Showing results (121-130 of 229) with videos related to
Sort By:
Pageof 23
Advances in Radiation Oncology|October 30, 2018
Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapyTommy Sheu, Sarah A Milgrom, Therese Y Andraos, et al.Journal of Neurointerventional Surgery|October 5, 2025
Supply cost and outcome comparison of nBCA, Onyx, and coils for middle meningeal artery embolizations: a single-center retrospective analysisKiernan Joseph Gunn, Eric Sleasman, Sajal Medha K Akkipeddi, et al.Plos One|September 5, 2015
Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185Yoko Tabe, Kensuke Kojima, Shinichi Yamamoto, et al.Journal of Spine Surgery (Hong Kong)|January 15, 2021
Multi-modal pain control regimen for anterior lumbar fusion drastically reduces in-hospital opioid consumptionYoji Ogura, Jeffrey L Gum, Portia Steele, et al.Blood Advances|August 19, 2024
Impact of PIK3CA gain and PTEN loss on mantle cell lymphoma biology and sensitivity to targeted therapiesNardjas Bettazova, Jana Senavova, Kristyna Kupcova, et al.Blood|June 7, 2013
Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftmentV Lokesh Battula, Ye Chen, Maria da Graca Cabreira, et al.Biorxiv : the Preprint Server for Biology|February 8, 2024
Integrative genomic analysis identifies unique immune environments associated with immunotherapy response in diffuse large B cell lymphomaSravya Tumuluru, James K Godfrey, Alan Cooper, et al.British Journal of Haematology|September 4, 2018
Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinibPreetesh Jain, Rashmi Kanagal-Shamanna, Shaojun Zhang, et al.Head & Neck|April 4, 2017
Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphomaChelsea C Pinnix, Bouthaina S Dabaja, Sarah A Milgrom, et al.Molecular Cancer Research : MCR|February 14, 2023
Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) Overcomes Adaptive Drug Resistance in Acute Myelogenous LeukemiaSeemana Bhattacharya, Sujan Piya, Huaxian Ma, et al.Pageof 23